Skip to content
Skip to navigation
Skip to footer
Search
Menu
Search
Search
Search
Close
What science can do
What science can do
Stories of impact
Publications
Close
R&D
R&D
Our approach
Our approach to R&D
STEM at AstraZeneca
Precision medicine
Transformative science
Data science & AI
Clinical innovation
Our technologies
Next generation therapeutics
R&D strategic centres
Featured website
AstraZeneca Clinical Trials
Featured website
Open Innovation
Close
Our therapy areas
Our therapy areas
Oncology
BioPharmaceuticals
Cardiovascular, Renal and Metabolism
Respiratory & Immunology
Vaccines and Immune Therapies
Rare Disease
Pipeline
All medicines
Close
Our company
Our company
Our history
Our people
Our people
Oncology
BioPharmaceuticals
Rare Disease
Research & Development
Enabling functions
Operations
International
Our leadership
Cambridge
Gothenburg
Gaithersburg
Close
Careers
Careers
Great place to work
Inclusion and diversity
Learning and development
Employee resource groups
Close
Investors
Investor Relations (Global)
Investor Relations (Sweden)
Resources
Governance
Shareholder information
Dividend policy
Key facts
FAQs
Debt Investors
ADR Programme
Feature
Full Year and Q4 2024 results
Feature
Results and presentations
Close
Media
Media
Press Releases
Articles
Image library
Broadcast videos
Archive
Media contacts
Investor Day 2024
Close
Sustainability
Sustainability
Access to healthcare
Overview Access to healthcare
Equitable access
Affordability and pricing
Health system resilience
Environmental protection
Overview Environmental protection
Ambition Zero Carbon
Product sustainability
Natural resources
Ethics and transparency
Overview Ethics and transparency
Ethical business culture
Inclusion and diversity
Workforce safety and health
Partnerships, alliances and recognition
Supporting our communities
Resources
Sustainability report